{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:37:53Z","timestamp":1773477473716,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23bm1223011h0001"],"award-info":[{"award-number":["23bm1223011h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K21612"],"award-info":[{"award-number":["20K21612"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21F21108"],"award-info":[{"award-number":["21F21108"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.exphem.2023.104138","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T23:24:40Z","timestamp":1703546680000},"page":"104138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Purging myeloma cell contaminants and simultaneous expansion of peripheral blood-mobilized stem cells"],"prefix":"10.1016","volume":"131","author":[{"given":"Kantaro","family":"Ishitsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishikii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-2908","authenticated-orcid":false,"given":"Takaharu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0871-9883","authenticated-orcid":false,"given":"Ayano","family":"Sugiyama-Finnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-3854","authenticated-orcid":false,"given":"Satoshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2023.104138_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","article-title":"Stem cells: units of development, units of regeneration, and units in evolution","volume":"100","author":"Weissman","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2023.104138_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.exphem.2023.104138_bib0003","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMct0805626","article-title":"Autologous hematopoietic stem-cell transplantation for multiple myeloma","volume":"360","author":"Harousseau","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2023.104138_bib0004","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1301077","article-title":"Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma","volume":"369","author":"Stiff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2023.104138_bib0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbmt.2009.11.012","article-title":"Poor mobilization of hematopoietic stem cells\u2014definitions, incidence, risk factors, and impact on outcome of autologous transplantation","volume":"16","author":"Wuchter","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2023.104138_bib0006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI15994","article-title":"Disruption of the CXCR4\/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide Find the latest version: disruption of the CXCR4\/CXCL12 chemotactic interaction during hematopoietic stem cell mobi","volume":"111","author":"L\u00e9vesque","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2023.104138_bib0007","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"Dipersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0008","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00432-004-0635-y","article-title":"Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation","volume":"131","author":"Vogel","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.exphem.2023.104138_bib0009","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/cancers13164047","article-title":"Aberrant plasma cell contamination of peripheral blood stem cell autografts, assessed by next-generation flow cytometry, is a negative predictor for deep response post autologous transplantation in multiple myeloma; A prospective study in 199 Patients","volume":"13","author":"Kostopoulos","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2023.104138_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41408-023-00842-6","article-title":"Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients","volume":"13","author":"Pasvolsky","year":"2023","journal-title":"Blood Cancer J"},{"issue":"7950","key":"10.1016\/j.exphem.2023.104138_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-023-05739-9","article-title":"Chemically defined cytokine-free expansion of human haematopoietic stem cells","volume":"615","author":"Sakurai","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2023.104138_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/stemcells.18-2-87","article-title":"Clinical applications of CD34 + peripheral blood progenitor cells (PBPC)","volume":"18","author":"Vogel","year":"2000","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2023.104138_bib0013","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/\u03b3cnull mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2023.104138_bib0015","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2023.104138_bib0016","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.exphem.2023.104138_bib0017","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood.2020005827","article-title":"Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171","volume":"136","author":"Subramaniam","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592348","article-title":"Limited mitochondrial activity coupled with strong expression of CD34, CD90 and EPCR determines the functional fitness of ex vivo expanded human hematopoietic stem cells","volume":"8","author":"Papa","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.exphem.2023.104138_bib0019","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V99.5.1602","article-title":"Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia","volume":"99","author":"Tomer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.stem.2020.12.002","article-title":"UM171 preserves epigenetic marks that are reduced in ex vivo culture of human HSCs via potentiation of the CLR3-KBTBD4 complex","volume":"28","author":"Chagraoui","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2023.104138_bib0021","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood.2021010745","article-title":"HLF expression defines the human hematopoietic stem cell state","volume":"138","author":"Lehnertz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0022","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.4049\/jimmunol.180.11.7358","article-title":"Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte\/macrophage progenitor stages to maintain cell survival","volume":"180","author":"Kikushige","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2023.104138_bib0023","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2002-06-1694","article-title":"Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD\/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells","volume":"102","author":"Sitnicka","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.exphem.2023.104138_bib0024","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4161\/cc.10.10.15619","article-title":"Thrombopoietin and hematopoietic stem cells","volume":"10","author":"De Graaf","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exphem.2023.104138_bib0025","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2023.104138_bib0026","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2023.104138_bib0027","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.stem.2021.07.003","article-title":"TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate","volume":"28","author":"Garc\u00eda-Prat","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2023.104138_bib0028","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd1159","article-title":"Bortezomib","volume":"2","author":"Paramore","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2023.104138_bib0029","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-10-459883","article-title":"Carfilzomib","volume":"121","author":"Kortuem","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0030","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","article-title":"Panobinostat for the treatment of multiple myeloma","volume":"21","author":"Laubach","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2023.104138_bib0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ddtec.2019.02.004","article-title":"Cereblon modulators: low molecular weight inducers of protein degradation","volume":"31","author":"Chamberlain","year":"2019","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.exphem.2023.104138_bib0032","unstructured":"Ebina W. Combinatorial pathway modulation toward ex vivo maintenance and propagation of hematopoietic stem cells. DASH. HARVARD.edu. 2016. Available at: http:\/\/nrs.harvard.edu\/urn-3:HUL.InstRepos:33493367. Accessed November 14, 2023."},{"key":"10.1016\/j.exphem.2023.104138_bib0033","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","article-title":"TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells","volume":"13","author":"Gazitt","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2023.104138_bib0034","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","article-title":"NEOPLASIA TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.104138_bib0035","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","article-title":"TRAIL signalling: decisions between life and death","volume":"39","author":"Falschlehner","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2023.104138_bib0036","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1158\/0008-5472.CAN-11-0842","article-title":"Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma","volume":"71","author":"Yang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2023.104138_bib0037","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.bbmt.2012.04.004","article-title":"Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus","volume":"18","author":"Bartee","year":"2012","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23017769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23017769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:17:29Z","timestamp":1728400649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X23017769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S0301472X23017769"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2023.104138","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purging myeloma cell contaminants and simultaneous expansion of peripheral blood-mobilized stem cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2023.104138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104138"}}